Document ID: chunk:federal_register_of_legislation:F2024L01543:front:0:p1
Version: federal_register_of_legislation:F2024L01543
Segment Type: other
Provision Reference: 
Character Range: 0–3127

PB 128 of 2024

National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment (December Update) Instrument 2024

National Health Act 1953

I, EDEN SIMON, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make this Instrument under subsection 100(2) of the National Health Act 1953.

Dated 28 November 2024

EDEN SIMON
Assistant Secretary (Acting)
Pricing and PBS Policy Branch
Technology Assessment and Access Division

Contents
1 Name
2 Commencement
3 Authority
4 Schedules
Schedule 1—Amendments
National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024
(PB 31 of 2024) 2

     1.                Name
 1.            This instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment (December Update) Instrument 2024
 2.            This instrument may also be cited as PB 128 of 2024.

     1.                Commencement
        1.            Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1                          Column 2         Column 3
Provisions                        Commencement     Date/Details
1.  The whole of this instrument  1 December 2024  1 December 2024

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
        1.             Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

     1.                Authority
    This instrument is made under subsection 100(2) of the National Health Act 1953.

     1.                Schedules
    Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024 (PB 31 of 2024)

     1.            Part 1, Section 5 Definitions
Insert in alphabetical order:
active ingredient, in relation to a chemotherapy drug, means a drug that is mentioned in the name of the chemotherapy drug.
Note: A chemotherapy drug may be a medicinal preparation containing multiple drugs (see the definition of listed drug in Part VII of the Act).

     1.            Part 2, Division 2, Subsection 14(2)
Before "in relation to", insert "(the maximum amount column)".

     1.            Part 2, Division 2, Subsection 14(3)
Omit 'column of the table in Part 2 of Schedule 1 headed "Maximum Amount" in relation to', substitute 'maximum amount column in relation to'.

     1.            At the end of